Navigation Links
WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
Date:2/21/2008

Earnings Conference Call to be held on March 13, 2008 at 9:00 am (Eastern)

/ 6:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong)

SHANGHAI, China, Feb. 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release unaudited financial results for the fourth quarter and full year ended December 31, 2007 after the US market close on Wednesday, March 12, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The earnings release will be available on the investor relations page of its website at http://www.wuxipharmatech.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 9:00 am (Eastern) / 6:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong) on Thursday, March 13, 2008 to discuss its 2007 fourth quarter and full year financial results and recent business activity. The conference call may be accessed by calling:

United States

Toll Free: +1-888-596-2633

Toll: +1-913-312-1234

China, Northern Region

Toll Free: +10-800-714-0970

China, Southern Region

Toll Free: +10-800-140-0945

Hong Kong

Toll Free: +800-965-503

United Kingdom

Toll Free: +0808-101-1402

A telephone replay will be available shortly after the call until April 12, 2008 at (US) +1-888-203-1112/ (HK) +800-901-108 / (China, Southern Region) +10-800-140-1178 / (China, Northern Region)
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. WuXi PharmaTech Completes Acquisition of AppTec
2. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
3. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
4. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
5. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
8. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
9. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
10. WuXi PharmaTech Announces Second Quarter 2007 Results
11. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... SAN DIEGO, Nov. 9 NexBio, Inc. an...nnual American College of Allergy, Asthma, and Imm...ntitled "DAS181 (Fludase®), a Sialidase, Decr...matory Effects in Animal Models of Asthma". ,, ...ad spectrum host-targeting drug candidate being st...
(Date:11/8/2009)...ember 6, 2009 As global temperatures and energy c... will be key to a sustainable future. An attract...o studies published online in Genome Research ( ...ome structures of bioethanol-producing microorgani...l in developing new technologies needed to impleme...
(Date:11/6/2009)... AURORA, Ontario, Nov. 6 ...ets: HXBPF) today announced that John Docherty, pr...at Merriman Curhan Ford,s 6th annual Investor Summ...Hotel in New York City. Mr. Docherty will provide...lopment programs L-DOS47 and Topical Interferon Al...
(Date:11/6/2009)... CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolyti...s" or the "Company") today announced updated resul...) in patients with sarcomas metastatic to the lung...ctive Tissue Oncology Society Meeting held in Miam...ster presentation, entitled "A Phase II Study of I...
Breaking Biology Technology:NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
...ence,Corporation (Nasdaq: CSCX ), a global leader...bilitation, and informatics products, announced to...nancial results on Wednesday,April 30, 2008 after ...erence call with analysts and investors for 4:30 p...for the first quarter and current business,develop...
...cancer would find a noninvasive method to determin...ause low levels of oxygen in a tumor have been lin... to image the surrounding organs and tissues at th...umors in mice by Murali Krishna and colleagues, at...importance of this technical advance for furtherin...
...st-selling,biologics developed during the boom yea... hormone (hGH) and insulin, have lost patent,prote...y represent a market,of $40 billion. This opens up...atory hurdles can be overcome, according to a new ...orld Market for Biosimilars., Worldwide interest ...
Other Biology Technology:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles 2
(Date:11/9/2009)...David Queller and Joan Strassmann argue in a new p...n components, from the genetic level on up, give a...ing is an animal, a plant, a bacteria or a colony...e an organism, such as individuality or even membe... achieve organismality. What is necessary, they ar...
(Date:11/9/2009)... / b3c newswire / - Today, TNO, a Dutch contrac...ican organization for contract research and consul...etter of intent with regard to TNOs dynamic in vi...tent proposes a collaboration in which Seventh Wav...n in North America. The TIM systems will be used t...
(Date:11/8/2009)... a gene through deletion of genetic material on ch...lities in learning and behavior, said a consortium...( www.bcm.edu ) in a report that appears online to...search goes about 95 percent of the way to pinning... to this gene," said Dr. Arthur L. Beaudet ( http:...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Developmental delay could stem from nicotinic receptor deletion 2Diagnostic tools and innovative therapies improve patient prognosis 53431 1Diagnostic tools and innovative therapies improve patient prognosis 53431 2Diagnostic tools and innovative therapies improve patient prognosis 53431 3Diagnostic tools and innovative therapies improve patient prognosis 53431 4Diagnostic tools and innovative therapies improve patient prognosis 53431 5Diagnostic tools and innovative therapies improve patient prognosis 53431 6Rock Climbing Injury Rate Soaring 53430 1Rock Climbing Injury Rate Soaring 53430 2Men Around the World Seek Cosmetic Surgery 53428 1Men Around the World Seek Cosmetic Surgery 53428 2
...sor of Clinical Tropical Medicine at the London Sc...d the first Hideyo Noguchi Africa Prize for resear...eir Majesties the Emperor and Empress of Japan at ...ideyo Noguchi Prize aims to award individuals with...research and health services, and seeks to encoura...
... Savage-Rumbaugh, Scientist With Special Standing ...eld of ape language and cognition studies, recentl...egree conferred in the 103-year history of her alm... , Savage-Rumbaugh, an internationally known prim...trated that through early rearing experiences, bon...
...local-source energy. Faster, more reliable technol...anguage. Medical care tailored to your DNA, or neu...ological diseases and injuries. , Five University...tures of energy, health, and technology as part of...they received this year from the National Science ...
Other Biology News:Professor Brian Greenwood awarded first Hideyo Noguchi Africa Award 2Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 2Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 3Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 4Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 5Pitt faculty receive awards to explore next-generation technologies 2Pitt faculty receive awards to explore next-generation technologies 3Pitt faculty receive awards to explore next-generation technologies 4
Luminex 100 IS System from Luminex Corporation
GIBCO Water Distilled Sterile from Invitrogen
GIBCO Water distilled from Invitrogen
Yeast Deletion Parental Strains S. cerevisiae Hansen BY4742 from Invitrogen
Biology Products: